You are on Trendlyne United States. Click here to go to India website or make United States as your default
  1. MARKETS
  2. SECTOR : HEALTHCARE EQUIPMENT & SUPPLIES
  3. INDUSTRY : MEDICAL DISTRIBUTORS
  4. CENCORA INC.

Cencora Inc. XNYS: COR

Cencora Inc. Live Share Price Today, Share Analysis and Chart

Turnaround Potential
Download real time

286.74 2.30 (0.81%)

Near 52W High of $296.65

1.1M XNYS Volume

XNYS 17 Apr, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
Board Meeting
The next board meeting for Cencora Inc. is on 01 May 2025 for the purpose of Cencora Inc Second Quarter Earnings Results for 2025 See details

Cencora Inc. Key Metrics

Select

Market Capitalization

Below industry Median
55,545.1

PE TTM

Below industry Median
39.8

PEG TTM

Negative PEG TTM
-1.6

Price to Book

High in industry
245.1

Institutional holding current Qtr %

Market Runner Up
101.6

Revenue Growth Qtr YoY %

Below industry Median
12.8

Operating Revenue growth TTM %

Below industry Median
11.6

Net Profit Qtr Growth YoY %

Negative Net Profit Qtr Growth YoY %
-18.8

Net Profit TTM Growth %

Negative Net Profit TTM Growth %
-25.2

Operating Profit Margin Qtr %

Low in industry
1

Operating Profit Margin TTM %

Below industry Median
1

Piotroski Score

Below industry Median
6

Rel Perf vs Sector quarter%

25.7

ROE Annual %

Market Leader
258.4

RoA Annual %

Below industry Median
2.3
All financials are in USD Million and price data in USD
VIEW MORE
Durability score
Medium Financial Strength
44.4 / 100
Valuation Score
Mid Valuation
30.8 / 100
Momentum Score
Technically Moderately Bullish
68.3 / 100
Turnaround Potential These stocks may be affordable or expensive due to their medium quality and a good technical scoring. However, their reasonable financials successfully attract investors. View Similar Embed DVM
Analyst Price Target
295
1Yr Price target upside is 3%
15 analysts

21

S

9

W

5

O

0

T

SWOT Analysis

Cencora Inc. Live Price Chart

Switch to TradingView
Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Created with Highcharts 7.2.2Sep '22Sep '23Sep '24Sep '25Sep '26200k250k300k350k400kActual RevenueAvg. Estimate
Hit

Cencora Inc.'s Revenue was higher than average estimate 3 times in past 3 years

EPS forecast

Current EPS
7.5
Avg. Estimate
12
Low Estimate
9.7
High Estimate
13.5
Current EPS
Avg. Estimate
Hit

EPS is expected to grow by 59.2% in FY25

Consensus Recommendation

17 ANALYST Recommendations
BUY

Created with Highcharts 7.2.21Sell6Hold1Buy9Strong Buy

The consensus recommendation from 17 analysts for Cencora Inc. is BUY

Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get

Cencora Inc. Stock Analysis

Cencora Inc. stock analysis with key metrics, changes, and trends.

Cencora Inc. MetricVALUECHANGE %TRENDANALYSIS
Annual Revenue$293,958.6 M12.12%positive

Annual Revenue rose 12.12%, in the last year to $293,958.6 M. Its sector's average revenue growth for the last fiscal year was 8.57%.

Annual Net Profit$1,509.12 M13.53%negative

Annual Net Profit fell 13.53% in the last year to $1,509.12 M. Its sector's average net profit growth for the last fiscal year was 4.36%.

Price to Earning Ratio39.78-negative

Price to Earning Ratio is 39.78, higher than its sector PE ratio of 29.09.

Stock Price$286.7419.91%positive

Stock Price rose 19.91% and outperformed its sector by 14.48% in the past year.

Quarterly Revenue$81,487.06 M12.78%positive

Quarterly Revenue rose 12.78% YoY to $81,487.06 M. Its sector's average revenue growth YoY for the quarter was 8.5%.

Quarterly Net profit$488.6 M18.77%negative

Quarterly Net profit fell 18.77% YoY to $488.6 M. Its sector's average net profit growth YoY for the quarter was 32.89%.

Debt to Equity Ratio6.79-negative

Debt to Equity Ratio of 6.79 is higher than 1. This implies that company assets are financed through debt.

Return on Equity(ROE)258.42 %258.42%positive

Return on Equity(ROE) for the last financial year was 258.42%, more than 20% in the last financial year, indicating an efficient use of shareholder's capital to generate profit.

Mutual Fund Holding168.87 %0.18%positive

Mutual Fund Holding increased by 0.18% in the last quarter to 168.87.

Promoter Share Holding0.32 %-0.01%negative

Promoter Share Holding decreased by 0.01% in the most recent quarter to 0.32%.

Interest Coverage Ratio9.06-positive

Interest Coverage Ratio is 9.06, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

Institutional Holding101.58 %0.96%positive

Institutional Holding increased by 0.96% in the last quarter to 101.58.

VIEW LESS


Loading data..

Cencora Inc. - Company Profile

What does Cencora Inc. do?

Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the us pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.

Cencora Inc. Management structure

All Gross Remunerations are in USD
Mr. Steven H. Collis
Chairman of the Board, President and Chief Executive Officer
18.48 M
2024
Gross Remuneration
Year
Mr. Robert P. Mauch
Director, President and Chief Executive Officer
9.25 M
2024
Gross Remuneration
Year
Mr. James F. Cleary, Jr
Executive Vice President and Chief Financial Officer
9 M
2024
Gross Remuneration
Year
Ms. Elizabeth S. Campbell
Executive Vice President and Chief Legal Officer
7.67 M
2024
Gross Remuneration
Year
Ms. Silvana Battaglia
Executive Vice President and Chief Human Resources Officer
5.32 M
2024
Gross Remuneration
Year
Ms. Gina K. Clark
Executive Vice President, Chief Communications Officer and Chief Administration Officer
-
2024
Gross Remuneration
Year

Cencora Inc. Board of directors

All Gross Remunerations are in USD
Mr. Richard W. Gochnauer
Independent Director
-
2025
Gross Remuneration
Year
Ms. Kathleen W. Hyle
Independent Director
-
2025
Gross Remuneration
Year

Cencora Inc. FAQ

How is Cencora Inc. today?
Cencora Inc. today is trading in the green, and is up by 0.81% at 286.74.
Cencora Inc. is currently trading up 0.81% on an intraday basis. In the past week the stock rose 0.85%. stock has been up 18.46% in the past quarter and rose 19.91% in the past year. You can view this in the overview section.